Taking losartan might allow patients with brain cancer to continue receiving immune checkpoint inhibitors without experiencing the medications’ potentially deadly side effect.
Browse Radiation Oncology News
The team's findings sugggest that these data registries do not reflect the true landscape of cancer patients in the US.
Mathematical Model Predicts Long-Term Effectiveness of COVID-19 Vaccine Booster Doses in Different Patient Populations
The model also makes predictions under potential future scenarios (such as the emergence of SARS-CoV-2 variants with greater immune evasion) and reveals the benefits of the new bivalent vaccines.
A team led by scientists at Massachusetts General Hospital (MGH) recently found that the skin produces the hormone β-endorphin in response to radiation therapy, and that elevated β-endorphin levels contribute to fatigue after treatment.
The team expects this study to help other researchers better understand the physical and chemical effects of radiation damage.
Research Spotlight: Learning More About Treatment Resistance in A Highly Fatal Form of Pancreatic Cancer
A high-resolution molecular framework sheds light on the inter- and intratumoral diversity of pancreatic cancer, spatial organization into discrete communities, treatment-associated remodeling and clinically relevant prognostication.
Among both men and women, non-smokers and smokers, lung cancer remains the leading cause of cancer-related death. n recognition of Lung Cancer Awareness Month, Massachusetts General Hospital physicians answer common questions related to lung cancer.
The new agent, called TB-403, was well tolerated and induced stabilization of the disease in some medulloblastoma patients.
Scientists develop and monitor two approaches to fix blood vessel abnormalities that make tumors difficult to treat
Scientists develop and monitor two approaches to fix blood vessel abnormalities that make tumors difficult to treat. Scientists develop and monitor two approaches to fix blood vessel abnormalities that make tumors difficult to treat. Key Takeaways
Diversity in U.S. medicine is not keeping pace with population changes, analysis finds. Diversity in U.S. medicine is not keeping pace with population changes, analysis finds. Key Takeaways • A new study assessed trends in the makeup of clinical